Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1089

1.

Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?

Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Eckel HE, Pfister HJ, Fuchs PG.

Med Microbiol Immunol. 2003 Aug;192(3):129-32. Epub 2002 Sep 14.

PMID:
12920586
2.

Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.

Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ, Fuchs PG.

Cancer. 2001 Dec 1;92(11):2875-84.

PMID:
11753961
3.
4.

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D.

J Natl Cancer Inst. 2000 May 3;92(9):709-20.

PMID:
10793107
5.

Human papillomaviruses in lymph node neck metastases of head and neck cancers.

Hoffmann M, Gottschlich S, Görögh T, Lohrey C, Schwarz E, Ambrosch P, Kahn T.

Acta Otolaryngol. 2005 Apr;125(4):415-21.

PMID:
15823814
6.

[Causal association between human papilloma virus infection and head and neck and esophageal squamous cell carcinoma].

Szentirmay Z, Szántó I, Bálint I, Pólus K, Remenár E, Tamás L, Szentkúti G, Melegh Z, Nagy P, Kásler M.

Magy Onkol. 2002;46(1):35-41. Epub 2003 Feb 3. Hungarian.

8.
9.

The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome.

Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MC.

Mod Pathol. 2008 Apr;21(4):376-86. doi: 10.1038/modpathol.3800979. Epub 2008 Jan 25.

10.

Presence of HPV in head and neck tumours: high prevalence in tonsillar localization.

Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M.

J Exp Clin Cancer Res. 2004 Dec;23(4):561-6.

PMID:
15743024
11.

Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone.

Chung YL, Lee MY, Horng CF, Jian JJ, Cheng SH, Tsai SY, Hsieh CI, Yen LK, Lin CY.

Head Neck. 2009 Jan;31(1):9-20. doi: 10.1002/hed.20913.

PMID:
18767174
12.

Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.

Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM.

Clin Cancer Res. 2008 Jan 15;14(2):366-9. doi: 10.1158/1078-0432.CCR-07-1402.

13.

Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.

Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH.

J Natl Cancer Inst. 2004 Jul 7;96(13):998-1006.

PMID:
15240783
14.
16.

Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.

Klussmann JP, Gültekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG.

Am J Pathol. 2003 Mar;162(3):747-53.

17.

Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Kreimer AR, Clifford GM, Boyle P, Franceschi S.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75. Review.

18.

Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma.

Begum S, Cao D, Gillison M, Zahurak M, Westra WH.

Clin Cancer Res. 2005 Aug 15;11(16):5694-9.

19.

Human papillomavirus in oral exfoliated cells and risk of head and neck cancer.

Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, Turek LP.

J Natl Cancer Inst. 2004 Mar 17;96(6):449-55.

PMID:
15026470
20.

Supplemental Content

Support Center